Effects of Nerve Growth Factor (NGF) and Other Fibroblast-derived Growth Factors on Immature Human Mast Cells (HMC-1)

Overview

Journal Immunology

Specialty Allergy & Immunology

Date 1998 Oct 15

PMID 9771435

Citations 14

Authors

P Welker

J Grabbe

A Grutzkau

B M Henz

Affiliations

Soon will be listed here.

Abstract

We have previously shown that fibroblast and keratinocyte supernatants up-regulate expression of mast cell characteristics in the human immature mast cell line HMC-1. This effect could not be induced in HMC-1 cells by the well-known mast cell growth factor stem cell factor (SCF), probably due to mutations of the SCF receptor c-Kit in these cells. Here we report the effects of several known fibroblast- and keratinocyte-derived growth factors, namely nerve growth factor (NGF), basic fibroblast growth factor, platelet-derived growth factor and transforming growth factor-beta, on mast cell differentiation, using HMC-1 cells as a model. NGF, at 0.1-50 ng/ml concentrations, caused a marked, dose-dependent up-regulation of tryptase, Fc epsilon RI and histamine within 10 days of culture, associated with an enhanced expression of mRNA for Fc epsilon RI and mast cell tryptase. On restriction analysis, only mast cell beta-tryptase, but not alpha-tryptase, could be demonstrated. Furthermore, the high-affinity NGF receptor (TrkA) was found at both the transcriptional and protein levels, while expression of the low-affinity NGF receptor was detectable at the mRNA level only. None of the other growth factors caused a significant alteration of the mast cell markers studied when added to HMC-1 cells at concentrations known to be biologically active in other culture systems. Immature human mast cells are thus induced to assume a more mature phenotype in vitro in response to NGF, most probably via stimulation of the high-affinity NGF receptor expressed on these cells. Besides SCF, NGF should therefore be considered as an additional mast cell growth factor that contributes to human mast cell maturation at tissue sites.

Citing Articles

A Microglial Function for the Nerve Growth Factor: Predictions of the Unpredictable.

Tiberi A, Capsoni S, Cattaneo A Cells. 2022; 11(11).

PMID: 35681529 PMC: 9180430. DOI: 10.3390/cells11111835.

New Insights into the Pathogenesis of Systemic Mastocytosis.

Li Z Int J Mol Sci. 2021; 22(9).

PMID: 34063170 PMC: 8125314. DOI: 10.3390/ijms22094900.

The importance of the neuro-immuno-cutaneous system on human skin equivalent design.

Vidal Yucha S, Tamamoto K, Kaplan D Cell Prolif. 2019; 52(6):e12677.

PMID: 31441145 PMC: 6869210. DOI: 10.1111/cpr.12677.

Mast cells as sources of cytokines, chemokines, and growth factors.

Mukai K, Tsai M, Saito H, Galli S Immunol Rev. 2018; 282(1):121-150.

PMID: 29431212 PMC: 5813811. DOI: 10.1111/imr.12634.

Activation of TRKA receptor elicits mastocytosis in mice and is involved in the development of resistance to KIT-targeted therapy.

Yang M, Pan Z, Huang K, Busche G, Feuerhake F, Chaturvedi A Oncotarget. 2017; 8(43):73871-73883.

PMID: 29088753 PMC: 5650308. DOI: 10.18632/oncotarget.18027.

References

Tuveri M, Passiu G, Mathieu A, Aloe L . Nerve growth factor and mast cell distribution in the skin of patients with systemic sclerosis. Clin Exp Rheumatol. 1993; 11(3):319-22. View

Czarnetzki B, Grabbe J, Kolde G, Kruger-Krasagakes S, Welker P, Zuberbier T . Mast cells in the cytokine network: the what, where from and what for. Exp Dermatol. 1995; 4(4 Pt 2):221-6. DOI: 10.1111/j.1600-0625.1995.tb00249.x. View

Kannan Y, Matsuda H, Ushio H, Kawamoto K, Shimada Y . Murine granulocyte-macrophage and mast cell colony formation promoted by nerve growth factor. Int Arch Allergy Immunol. 1993; 102(4):362-7. DOI: 10.1159/000236584. View

Horigome K, Bullock E, Johnson Jr E . Effects of nerve growth factor on rat peritoneal mast cells. Survival promotion and immediate-early gene induction. J Biol Chem. 1994; 269(4):2695-702. View

Herrmann J, Menter D, Hamada J, Marchetti D, Nakajima M, Nicolson G . Mediation of NGF-stimulated extracellular matrix invasion by the human melanoma low-affinity p75 neurotrophin receptor: melanoma p75 functions independently of trkA. Mol Biol Cell. 1993; 4(11):1205-16. PMC: 275754. DOI: 10.1091/mbc.4.11.1205. View

Mahadeo D, Kaplan L, Chao M, Hempstead B . High affinity nerve growth factor binding displays a faster rate of association than p140trk binding. Implications for multi-subunit polypeptide receptors. J Biol Chem. 1994; 269(9):6884-91. View

Huang S, Terstappen L . Lymphoid and myeloid differentiation of single human CD34+, HLA-DR+, CD38- hematopoietic stem cells. Blood. 1994; 83(6):1515-26. View

Leon A, Buriani A, Dal Toso R, Fabris M, Romanello S, Aloe L . Mast cells synthesize, store, and release nerve growth factor. Proc Natl Acad Sci U S A. 1994; 91(9):3739-43. PMC: 43657. DOI: 10.1073/pnas.91.9.3739. View

Siraganian R . Refinements in the automated fluorometric histamine analysis system. J Immunol Methods. 1975; 7(2-3):283-90. DOI: 10.1016/0022-1759(75)90025-3. View

10.

Schulz B, Vakilzadeh F, Czarnetzki B . Electron microscopical evidence for a direct contact between nerve fibres and mast cells. Acta Derm Venereol. 1981; 61(6):465-9. DOI: 10.2340/0001555561465469. View

11.

Ullrich A, Gray A, BERMAN C, Dull T . Human beta-nerve growth factor gene sequence highly homologous to that of mouse. Nature. 1983; 303(5920):821-5. DOI: 10.1038/303821a0. View

12.

Czarnetzki B, Figdor C, Kolde G, Vroom T, Aalberse R, De Vries J . Development of human connective tissue mast cells from purified blood monocytes. Immunology. 1984; 51(3):549-54. PMC: 1454453. View

13.

Mazurek N, Weskamp G, Erne P, Otten U . Nerve growth factor induces mast cell degranulation without changing intracellular calcium levels. FEBS Lett. 1986; 198(2):315-20. DOI: 10.1016/0014-5793(86)80428-8. View

14.

Katz F, Michalevicz R, Lam G, Hoffbrand A, Goldman J . Effect of platelet-derived growth factor on enriched populations of haemopoietic progenitors from patients with chronic myeloid leukaemia. Leuk Res. 1987; 11(4):339-44. DOI: 10.1016/0145-2126(87)90178-0. View

15.

Davies A, Bandtlow C, Heumann R, Korsching S, Rohrer H, Thoenen H . Timing and site of nerve growth factor synthesis in developing skin in relation to innervation and expression of the receptor. Nature. 1987; 326(6111):353-8. DOI: 10.1038/326353a0. View

16.

Bienenstock J, Tomioka M, Matsuda H, Stead R, Quinonez G, SIMON G . The role of mast cells in inflammatory processes: evidence for nerve/mast cell interactions. Int Arch Allergy Appl Immunol. 1987; 82(3-4):238-43. DOI: 10.1159/000234197. View

17.

Tokunaga K, Nakamura Y, Sakata K, Fujimori K, Ohkubo M, Sawada K . Enhanced expression of a glyceraldehyde-3-phosphate dehydrogenase gene in human lung cancers. Cancer Res. 1987; 47(21):5616-9. View

18.

Deuel T . Polypeptide growth factors: roles in normal and abnormal cell growth. Annu Rev Cell Biol. 1987; 3:443-92. DOI: 10.1146/annurev.cb.03.110187.002303. View

19.

Butterfield J, Weiler D, Dewald G, Gleich G . Establishment of an immature mast cell line from a patient with mast cell leukemia. Leuk Res. 1988; 12(4):345-55. DOI: 10.1016/0145-2126(88)90050-1. View

20.

Keller J, Mantel C, Sing G, Ellingsworth L, Ruscetti S, Ruscetti F . Transforming growth factor beta 1 selectively regulates early murine hematopoietic progenitors and inhibits the growth of IL-3-dependent myeloid leukemia cell lines. J Exp Med. 1988; 168(2):737-50. PMC: 2189000. DOI: 10.1084/jem.168.2.737. View